SARS-CoV-2 Antigen test kits and COVID Antigen Digital Immunoassay readers (automated)

Sources Sought Notice Only. This is not a request for bids, quotes, or proposals. The purpose of this notice is to conduct market research and obtain information from qualified potential offerors. No formal solicitation document exists at this time. The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to these sources sought synopsis request.

This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued.

The Fayetteville VAMC located at 2300 Ramsey Street, Fayetteville, NC, 28301 is seeking potential sources capable of providing point of care COVID-19 Rapid Detection of SARS-CoV-2 Antigen test kits and Covid Antigen Digital Immunoassay readers (automated). COVID-19 Rapid Detection of SARS-CoV-2 Antigen test kits must be FDA EUA approved for and restricted to high complexity and moderate complexity. The kits and readers are required for the rapid detection of the presence or absence of SARS-CoV-2 antigens.

Respiratory specimens are taken at the point of care at inpatient, outpatient, and employee occupational health settings. Specimens are also collected for serially testing from asymptomatic individuals at the Fayetteville VA Medical Center and associated clinics. Responses to this source sought notice should include the following:

name and address of company, business size (large or small): identify whether or not firm falls into any of the following socioeconomic categories-8(a), HUBZone, Services Disabled Veteran-Owned/Veteran-Owned Small Business; provide a brief description of qualifications, capabilities statement, authorized distributor documentation, and any other pertinent information which demonstrates the ability to meet the above requirement. Â Subject line: COVID 19 kits and reader.

All responses shall be submitted in the form of email to Cherisse Hall Cherisse.Hall@va.gov. Telephone responses will not be accepted. Responses must be received in writing no later than 08:00am EST on September 30, 2025. NAICS 325413 In-Vitro Diagnostic Substance Manufacturing PSC 6640 Laboratory Equipment and Supplies